Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT1032250378Completed
Open-label, single-arm trial of rocuronium in None. Primary endpoint: Time from rocuronium administration to TOF ratio 0.9. Started Sep 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT1032250378.